A Cochrane review pooled nine trials of regulated medical cannabis for insomnia, covering 537 adults aged 18 to 76, and found ...

Could your handwriting offer clues into how your brain is aging?

Zero HIV Acquisitions Occurred Among Participants Receiving Twice-Yearly Lenacapavir During the 52-Week Study Period PURPOSE 5 Study Findings Highlight the Potential of Long-Acting HIV Prevention ...

Patients on Vafseo® (vadadustat) increased to approximately 11,500 at the end of Q3 2026 representing an increase of approximately 140% from the ...

Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced topline results from VOCAL, an ...

A major new review challenges the growing enthusiasm for medical cannabis as an insomnia treatment, finding little reliable ...

Eli Lilly, Novo Nordisk and Pfizer went head-to-head over weight-loss drugs, with the focus shifting from injectables to oral therapies. Eli Lilly gave the first public showing of orforglipron, an ...

Australians could soon be able to take one of the world’s most popular weight-loss medications in tablet form, following a ...

Australians who take weight-loss drugs will have more options as the first daily tablet version of a GLP-1 medication is ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, ...

Gilead will present an update from its HIV cure research program, exploring the immunogenicity and associated safety of amtabafusp alfa (GS-8588), a bispecific T-cell engager, in a Phase 1b study in ...

The Conference Board's October confidence index rose to 91.7, but expectations for the next six months remained subdued.